Open label, single-center, cross-over randomized, relative bioavailability study comparing a new pitolisant hydrochloride tablet formulation at 4 different strengths versus the marketed pitolisant (Wakix®) tablet formulation after single oral administrations in healthy subjects
P24-03
Phase 1 other active
Quick answer
Open label, single-center, cross-over randomized, relative bioavailability study comparing a new pitolisant hydrochloride tablet formulation at 4 different strengths versus the marketed pitolisant (Wakix®) tablet formulation after single oral administrations in healthy subjects for Narcolepsy, Narcolepsy with cataplexy is a Phase 1 program (other) at Bioprojet Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bioprojet Pharma
- Indication
- Narcolepsy, Narcolepsy with cataplexy
- Phase
- Phase 1
- Modality
- other
- Status
- active